Insider Transactions in Q3 2024 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
30,942
-8.25%
|
$1,082,970
$35.75 P/Share
|
|
Sep 27
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
32
-0.02%
|
$1,120
$35.0 P/Share
|
|
Sep 26
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
1,260
-0.66%
|
$44,100
$35.29 P/Share
|
|
Sep 25
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
2,357
-1.22%
|
$82,495
$35.06 P/Share
|
|
Sep 23
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
40,831
-8.9%
|
$1,429,085
$35.76 P/Share
|
|
Sep 20
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
79,411
-12.69%
|
$2,858,796
$36.73 P/Share
|
|
Sep 19
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
78,739
-10.53%
|
$2,834,604
$36.08 P/Share
|
|
Sep 18
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
1,554
-0.39%
|
$54,390
$35.03 P/Share
|
|
Sep 18
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,339
-1.64%
|
$79,526
$34.55 P/Share
|
|
Sep 18
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,390
-1.39%
|
$47,260
$34.55 P/Share
|
|
Sep 18
2024
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,976
-3.24%
|
$305,184
$34.41 P/Share
|
|
Sep 17
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
3,272
-0.82%
|
$114,520
$35.13 P/Share
|
|
Sep 16
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
1,320
-0.33%
|
$46,200
$35.04 P/Share
|
|
Sep 11
2024
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,270
-1.82%
|
$163,370
$31.89 P/Share
|
|
Sep 11
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,468
-1.45%
|
$45,508
$31.89 P/Share
|
|
Sep 11
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,161
-1.49%
|
$66,991
$31.89 P/Share
|
|
Sep 06
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
126,074
-28.16%
|
$4,034,368
$32.39 P/Share
|
|
Sep 06
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
BUY
Exercise of conversion of derivative security
|
Direct |
116,478
+8.36%
|
$1,164,780
$10.48 P/Share
|
|
Sep 05
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
1,577
-0.39%
|
$55,195
$35.03 P/Share
|
|
Sep 04
2024
|
John Cox CEO & President |
BUY
Open market or private purchase
|
Indirect |
32,000
+48.68%
|
$1,024,000
$32.83 P/Share
|
|
Sep 03
2024
|
Douglas Kerr Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,500
+50.0%
|
-
|
|
Sep 03
2024
|
Johanna Friedl Naderer Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,400
+50.0%
|
-
|
|
Aug 30
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
31,300
-3.67%
|
$1,408,500
$45.75 P/Share
|
|
Aug 29
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
56,408
-5.9%
|
$2,538,360
$45.5 P/Share
|
|
Aug 28
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
77,853
-7.04%
|
$3,425,532
$44.67 P/Share
|
|
Aug 27
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
65,403
-10.37%
|
$2,877,732
$44.28 P/Share
|
|
Aug 26
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
89,497
-6.31%
|
$4,027,365
$45.51 P/Share
|
|
Aug 23
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
85,088
-5.39%
|
$3,914,048
$46.09 P/Share
|
|
Aug 22
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
95,321
-5.29%
|
$4,384,766
$46.4 P/Share
|
|
Aug 21
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
135,763
-6.78%
|
$6,245,098
$46.76 P/Share
|
|
Aug 20
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
86,840
-2.64%
|
$3,994,640
$46.64 P/Share
|
|
Aug 19
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,636
-0.9%
|
$118,620
$45.5 P/Share
|
|
Aug 19
2024
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,910
-0.98%
|
$130,950
$45.5 P/Share
|
|
Aug 19
2024
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,321
-0.8%
|
$104,445
$45.5 P/Share
|
|
Aug 19
2024
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,705
-1.01%
|
$121,725
$45.5 P/Share
|
|
Aug 19
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
2,752
-1.21%
|
$123,840
$45.5 P/Share
|
|
Aug 19
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
126,032
-3.44%
|
$5,671,440
$45.9 P/Share
|
|
Aug 16
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
122,643
-3.04%
|
$5,518,935
$45.35 P/Share
|
|
Aug 15
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
180,891
-5.97%
|
$8,140,095
$45.46 P/Share
|
|
Aug 14
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
100,650
-6.09%
|
$4,327,950
$43.67 P/Share
|
|
Aug 13
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
133,985
-2.55%
|
$5,627,370
$42.81 P/Share
|
|
Aug 12
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
78,492
-2.12%
|
$3,375,156
$43.08 P/Share
|
|
Aug 09
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
92,164
-0.49%
|
$3,963,052
$43.34 P/Share
|
|
Aug 08
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
91,670
-0.48%
|
$3,850,140
$42.19 P/Share
|